|
BPI-572270 Clinical Trials
1 actively recruiting trial
Also known as: BPI-572270 Capsule
Pipeline
Phase 1/2: 1
Top Sponsors
- Betta Pharmaceuticals Co., Ltd.1
Indications
- Pancreatic Ductal Adenocarcinoma (PDAC)1
- Non-small Cell Lung Cancer (NSCLC)1
- Colorectal Cancer (CRC)1
- Advanced Solid Tumors1
- Lung Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.